default author photo

Mphatso Chaponda

University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme

SCHOLARLY PAPERS

2

DOWNLOADS

142

TOTAL CITATIONS

0

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

Randomised Controlled Trial of Pneumococcal Conjugate Vaccine Shows Protection Against Experimental Pneumococcal Carriage in First Human Infection Study in Africa

Number of pages: 30 Posted: 15 Dec 2022
Dingase Dula, Ben Morton, Tarsizio Chikaonda, Anthony Emeritus Chirwa, Edna Nsomba, Vitumbiko Nkhoma, Clara Ngoliwa, Simon Sichone, Bridgette Galafa, Godwin Tembo, Mphatso Chaponda, Neema Toto, Ralphael Kamng'ona, Lumbani Makhaza, Alfred Muyaya, John Ndaferankhande, Christopher Mkandawire, Lorensio Chimgoneko, Ndaziona Peter Kwanjo Banda, Jamie Rylance, Evaristar Kudowa, Ashleigh Howard, Tinashe Kenny Nyazika, Daniela M. Ferreira, Kondwani Jambo, Marc YR Henrion and Stephen B. Gordon
University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Liverpool - School of Tropical Medicine, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Kamuzu University of Health Sciences, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of North Carolina (UNC) at Chapel Hill - UNC-Project Malawi, University of Liverpool - School of Tropical Medicine, University of Liverpool - School of Tropical Medicine, University of Liverpool - School of Tropical Medicine, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme and University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme
Downloads 83

Abstract:

Loading...

Streptococcus pneumoniae, controlled Human infection Model, Pneumococcal carriage, Nasal, Mucosal inflammation, Malawi

2.

Whole Cell Inactivated Poly-Bacterial Preparation MV130 Effect on Nasal Mucosal Immunity and Experimental Human Pneumococcal Carriage: Double-Blind Randomized Controlled Trial with Controlled Human Infection Model ​

Number of pages: 29 Posted: 17 Mar 2026
John Ndaferankhande, Kondwani Jambo, Tarsizio Chikaonda, Godwin Tembo, Laura Conejero, Marc YR Henrion, Evaristar Kudowa, Gareth Lipunga, Anthony Emeritus Chirwa, Edna Nsomba, Mphatso Chaponda, Mphatso Mailboy, Andrew Sigoloti, Shalom Songolo, Neema Toto, Faith Thole, Ndaziona Peter Banda, Bridgette Galafa, Glory Kadzanja, Morrison P. Kamanga, Lorensio Chimgoneko, Tiyamika Nthandira, Benson M. Tembo, Alfred Muyaya, Lumbani Makhaza, Bright Lipenga, Vusumuzi Katangwe, Gift Chiwala, Jonathan Grigg and Stephen B. Gordon
University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Immunotek, S.L., University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of North Carolina (UNC) at Chapel Hill - UNC-Project Malawi, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Queen Mary University of London and University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme
Downloads 59

Abstract:

Loading...

trained immunity, vaccine, CHIM, mucosal immunity, Streptococcus pneumoniae